-
EP3870601
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3870601
| EP3870601 - IL4/IL13 RECEPTOR MOLECULE FOR VETERINARY USE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 30.07.2021 Database last updated on 08.06.2024 | |
| Former | The international publication has been made Status updated on 02.05.2020 | Most recent event Tooltip | 20.10.2023 | Change - applicant | published on 22.11.2023 [2023/47] | Applicant(s) | For all designated states Elanco US Inc. 2500 Innovation Way Greenfield, IN 46140 / US | [2023/47] |
| Former [2021/35] | For all designated states Kindred Biosciences, Inc. 1555 Bayshore Highway, Suite 200 Burlingame, CA 94010 / US | Inventor(s) | 01 /
ZHAN, Hangjun 1555 Bayshore Highway Suite 200 Burlingame, California 94010 / US | 02 /
NGUYEN, Lam 1555 Bayshore Highway Suite 200 Burlingame, California 94010 / US | 03 /
QIAN, Fawn 1555 Bayshore Highway Suite 200 Burlingame, California 94010 / US | 04 /
LI, Shyr Jiann 1555 Bayshore Highway Suite 200 Burlingame, California 94010 / US | [2021/35] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2021/35] | Application number, filing date | 19875949.0 | 24.10.2019 | [2021/35] | WO2019US57922 | Priority number, date | US201862750782P | 25.10.2018 Original published format: US 201862750782 P | [2021/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020086886 | Date: | 30.04.2020 | Language: | EN | [2020/18] | Type: | A1 Application with search report | No.: | EP3870601 | Date: | 01.09.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.04.2020 takes the place of the publication of the European patent application. | [2021/35] | Search report(s) | International search report - published on: | US | 30.04.2020 | (Supplementary) European search report - dispatched on: | EP | 15.06.2022 | Classification | IPC: | C07K14/54, C07K14/715, C07K19/00 | [2021/35] | CPC: |
C07K14/7155 (EP,US);
A61K38/1793 (US);
A61K45/06 (US);
C07K16/00 (EP);
G01N33/5041 (EP);
G01N33/6869 (EP,US);
A61K38/00 (EP);
C07K2317/526 (EP);
C07K2319/30 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/35] | Title | German: | IL4/IL13-REZEPTORMOLEKÜL ZUR VERWENDUNG IN DER VETERINÄRMEDIZIN | [2021/35] | English: | IL4/IL13 RECEPTOR MOLECULE FOR VETERINARY USE | [2021/35] | French: | MOLÉCULE DU RÉCEPTEUR D'IL4/IL13 À USAGE VÉTÉRINAIRE | [2021/35] | Entry into regional phase | 13.05.2021 | National basic fee paid | 13.05.2021 | Search fee paid | 13.05.2021 | Designation fee(s) paid | 13.05.2021 | Examination fee paid | Examination procedure | 13.05.2021 | Examination requested [2021/35] | 16.01.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 13.05.2021 | Renewal fee patent year 03 | 12.10.2022 | Renewal fee patent year 04 | 13.10.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2005032164 (WATSON JOHANNA L [US], et al) [Y] 1-11,14-20 * figures 1-13; claims 1-33; sequences 2,4,6,9,10,11,15,16 *; | [Y]US2005191730 (KAROW MARGARET [US], et al) [Y] 1-11,14-20 * abstract * * paragraph [0082]; claims 1-30; sequences 8-16 *; | [Y]US2014255407 (KOENIG SCOTT [US]) [Y] 7-11 * abstract * * paragraph [0293] * * paragraph [0342]; sequence 154 * * paragraph [0348]; claims 1-20; sequence 158 *; | [XP]WO2018195388 (KINDRED BIOSCIENCES INC [US]) [XP] 1-6,14-20* the whole document *; | [Y] - "SubName: Full=Interleukin 13 receptor subunit alpha 1 {ECO:0000313|Ensembl:ENSCAFP00000030717};", UniProt, (20101130), Database accession no. E2QZ78, URL: EBI, XP002806685 [Y] 1-11,14-20 * the whole document * | [Y] - "SubName: Full=Interleukin 13 receptor subunit alpha 1 {ECO:0000313|Ensembl:ENSFCAP00000020222};", UniProt, (20130501), Database accession no. M3X0T0, URL: EBI, XP002806686 [Y] 1-11,14-20 * the whole document * | [Y] - "SubName: Full=Interleukin 13 receptor subunit alpha 1 {ECO:0000313|Ensembl:ENSECAP00000016953};", UniProt, (20110727), Database accession no. F6UHR5, URL: EBI, XP002806687 [Y] 1-11,14-20 * the whole document * | [Y] - TANG ET AL, "Recombinant canine IL-13 receptor alpha2-Fc fusion protein inhibits canine allergen-specific-IgE production in vitro by peripheral blood mononuclear cells from allergic dogs.", VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, (20011101), vol. 83, no. 1-2, doi:10.1016/S0165-2427(01)00378-6, ISSN 0165-2427, pages 115 - 122, XP055033881 [Y] 1-11,14-20 * abstract * DOI: http://dx.doi.org/10.1016/S0165-2427(01)00378-6 | International search | [A]US2005191730 (KAROW MARGARET [US], et al) [A] 1-4 * entire document *; | [A]US2009156421 (YANG XIAOKE [US], et al) [A] 1-4* entire document *; | [A]US2010278827 (CHUNG YONG-HOON [KR], et al) [A] 1-4 * entire document *; | [A]US2011151515 (HEIFETZ PETER [US], et al) [A] 1-4 * entire document *; | [A]US2013089893 (HOGARTH PHILLIP MARK [AU], et al) [A] 1-4 * entire document *; | [Y]EP2674440 (IBC PHARMACEUTICALS INC [US]) [Y] 1-4 * entire document *; | [Y]WO2018064190 (EPICENTRX INC [US]) [Y] 1-4 * entire document * |